Medidata
+ Click Therapeutics
Drug development no longer stops at pharmacology. Today, medicine and software can work together, and your trials need to support both.
Strengthen recruitment and retention. Capture real-world data in real time. Move Software-Enhanced (SE) Drugs™ and prescription digital therapeutics (PDTs) from development to delivery through Medidata and Click Therapeutics.
Digital Therapeutics Redefine Standard of Care
Differentiate Your Portfolio
Software-Enhanced Drugs™
Combine software with pharmacotherapy to create treatments tailored to patient needs. Differentiate your portfolio and support measurable clinical benefit.
Learn More About SE Drugs™
Bringing Digitally Enhanced Treatments to Patients
Digital and drugs are no longer separate paths. Build them together from the start.
Advance your pipeline with Software-Enhanced Drug™ treatments that integrate software into development and labeling strategy through Medidata and Click Therapeutics.
Featured Resource
Patients, Pipeline & Promise: Software-Enhanced Drugs™
Anthony Costello, Medidata CEO, and David Klein, Founder and CEO of Click Therapeutics, examine the shift toward Software-Enhanced Drugs™ and what it means for sponsors evaluating digital integration across development and commercialization.
